Tele: 561.316.3330
Breaking Medical Device News

Monday, September 20, 2021


HomeBed Techs Inc.First Antimicrobial Hospital Beds Using EPA Approved Antimicrobial LuminOre CopperTouch

First Antimicrobial Hospital Beds Using EPA Approved Antimicrobial LuminOre CopperTouch

Bed Techs, Inc. of Greendale, IN and LuminOre CopperTouch of Carlsbad, CA announced today its partnership that will incorporate antimicrobial surfaces on high touch surfaces of hospital beds. This coalition leverages Bed Techs’ unrivaled expertise in acute care hospital beds and LuminOre’s patented, EPA-registered CopperTouch technology.

Despite the healthcare industry’s extensive efforts and investments to improve infection control protocols, patients continue to be at risk for infection while in the hospital. Healthcare-associated infections (HAIs) are among the leading threats to patient safety; over a million HAIs occur across the U.S. health care system every year **.

Copper and copper alloys, when used on touch surfaces, are effective at killing harmful bacteria* that cause infections. EPA-registered LuminOre CopperTouch has been scientifically proven to eliminate 99.9% of harmful bacteria within 2 hours, and continues to kill 99% of bacteria, even after repeated contaminations.

Bed Techs Inc is a leading global supplier of reconditioned hospital beds, stretchers, medical equipment, and replacement bed parts for hospitals. The Company’s comprehensive line of products is used by health care providers around the world in acute care, long-term care, academic institutions, and in home-care settings. Bed Techs is able to upgrade used equipment to like-new condition at a significantly lower cost than comparable new equipment while providing a full range of warranty, maintenance, parts and financing services. The Company will be offering the option of Antimicrobial Copper on all of its reconditioned beds along with a customized rail exchange program and other products.

LuminOre CopperTouch Antimicrobial Surfaces  are the only EPA registered antimicrobial product which can be seamlessly applied to virtually any surface. This unique product makes copper’s natural antimicrobial properties available on items that would be too heavy if made of solid metal.

The company states that for the first time, hospitals now have the option of installing beds and bed components with antimicrobial surfaces that eliminate infection-causing bacteria on a continuous basis, demonstrating their desire to elevate the fight to reduce HAIs within the healthcare environment.

*Bacteria Staphylococcus aureus, Enterobacter aerogenes, Methicillin-Resistant Staphylococcus aureus (MRSA), Escherichia coli 0157:H7, and Pseudomonas aeruginosa.

Medical Device News Magazine
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected


Don't Miss

Mark Foster Joins Xenocor BOD

Foster is a versatile and visionary C-Suite executive who brings 20 years of general management and leadership experience from both venture-backed growth-stage organizations and world-class medical device companies

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

By using this website you agree to accept Medical Device News Magazine Privacy Policy